Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals - ECDC PPS validation protocol version 3.1.2.
The current protocol version 3.2.1 is the ECDC PPS validation protocol used during the second EU-wide PPS of HAIs and antimicrobial use in 2016–2017. This protocol version is an accompanying document to the ECDC protocol for the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals version 5.3.
Read more on this site
About ECDC Point prevalence survey
The ECDC point prevalence survey estimates the total burden (prevalence) of HAI and antimicrobial use in acute care hospitals in the EU and describes patients, invasive procedures, infections (sites, microorganisms including markers for antimicrobial resistance) and prescribed antimicrobials
Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – protocol version 5.3
Version 5.3 is the final protocol for the second EU-wide point prevalence survey (PPS 2016–2017). It contains major changes compared to protocol version 4.3 (PPS 2011–2012). Compared to versions 5.1 (January 2016) and 5.2 (May 2016), the current version only contains a few corrections, editorial changes and clarifications.
Related updates on antimicrobial resistance (AMR) and healthcare-associated infections
Data collection on COVID-19 outbreaks in closed settings with a completed vaccination programme: long-term care facilities, version 2.0
Rapid Risk Assessment: COVID-19 outbreaks in long-term care facilities in the EU/EEA in the context of current vaccination coverage
ECDC Rapid Risk Assessment: Several recent COVID-19 outbreaks in long-term care facilities in the EU/EEA
Antimicrobial resistance is the ability of a microorganism (e.g., a bacterium, a virus) to resist the action of an antimicrobial agent. The major cause of antimicrobial resistance remains the use of antimicrobials in human medicine.Read more
Approximately 4 100 000 patients are estimated to acquire a healthcare-associated infection in the EU each year. The number of deaths occurring as a direct consequence of these infections is estimated to be at least 37 000 and these infections are thought to contribute to an additional 110 000 deaths each year.Read more